Delivery Order SPE2D021DA002-SPE2D326F9461
Award Date 4/3/26
Potential Completion Date 4/6/26
Potential Value $1.6K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain division issued a $1,605.15 delivery order to DMS Pharmaceutical Group Inc. on April 1, 2026, for procainamide 1 gram/10 mL vials. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical and medical consumable supply to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned...
- The Defense Logistics Agency's Medical Supply Chain issued a $1,605.15 delivery order to DMS Pharmaceutical Group Inc. on April 1, 2026, for procainamide 1 gram/10 mL vials. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract established to supply pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a...
- The Defense Logistics Agency's Medical Supply Chain issued a $1,605.15 delivery order to DMS Pharmaceutical Group Inc. on April 1, 2026, for Procainamide 1 gram/10 mL vial (10 mL), with an ultimate completion date of April 2, 2026. This delivery order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $499.999 billion single-award IDC with a ceiling value of $499,999,999 and completion through December 31, 2036. The program...
- The Defense Logistics Agency's Medical Supply Chain issued a $1,605.15 delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, for procainamide 1 gram/10 mL vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract. PPV-G GEN V is the Defense Logistics Agency's $30.3 billion pharmaceutical prime vendor acquisition strategy authorizing issuance of firm fixed-price delivery orders for branded and generic prescription drugs,...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $3,210.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Procainamide 1 gram/10 mL vials. The contract, issued on January 13, 2026, with an ultimate completion date of January 14, 2026, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS...
- The Defense Logistics Agency's Medical Supply Chain issued a $248,324.18 delivery order to DMS Pharmaceutical Group Inc. on March 19, 2026, for pharmaceutical and medical supply products, with an ultimate completion date of April 26, 2027. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. The delivery order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award indefinite delivery...
- The Defense Logistics Agency issued a $65,066.40 delivery order to DMS Pharmaceutical Group Inc. on March 5, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. DMS Pharmaceutical Group Inc. is a woman-owned small business. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense medical facilities worldwide; DMS Pharmaceutical Group's...
- The Defense Logistics Agency issued a $1,197.85 delivery order to DMS Pharmaceutical Group Inc. on March 31, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products supporting federal defense medical supply needs. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. Place of performance is Park Ridge, Illinois. The order has a firm fixed price and an ultimate completion date of April 2, 2026. PPV-G...
- The Defense Logistics Agency issued a $1,506.40 delivery order to DMS Pharmaceutical Group Inc. on March 4, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler. The order is firm fixed price with place of performance in Park Ridge, IL and an ultimate completion date of March 5, 2026. The PPV-G GEN V is a $30.3 billion Defense...
- The Defense Logistics Agency issued a $5,205.40 delivery order to DMS Pharmaceutical Group Inc. on March 23, 2026, for provisc 10 mg/ml disposable syringes (0.85 ml). The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract supporting recurring pharmaceutical and medical supply needs for Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small...